Navigation Links
ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
Date:9/30/2009

WILMINGTON, Del., Sept. 30 /PRNewswire/ -- ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, has named Ellen M. Derrico as its chief marketing executive in a move to expand the company's market development.

Prior to joining ParagonRx, Derrico served as interim vice president of business development, sales and marketing for P-Wave and as executive advisor and consultant to Acurian and NanoScan Imaging. She is founder, chair and member of the Greater Philadelphia Senior Executive Group (GPSEG) Life Sciences Subgroup and is on the Board of Advisors for ChemPharma® professional association.

"I am thrilled to welcome Ellen to our team," said Jeff Fetterman, CEO of ParagonRx. "She is a great fit with our company and our mission. With her varied experiences in life sciences companies at different stages of company growth, Ellen will be a tremendous asset to ParagonRx, especially at such an important time in our development."

"Joining ParagonRx is a great opportunity for me to help build this company, expand our markets and leverage experiences and best practices," Derrico said.

Derrico has held various global marketing executive and leadership roles with large and small life sciences companies including Hewlett-Packard (now Agilent Life Sciences), BioPort Corporation (now Emergent BioSolutions), Fast Track Systems (now Medidata Solutions), TriPath Imaging (now Becton Dickenson) and SAP Life Sciences Business Unit. Derrico began her career in pharmaceutical R&D with G.D. Searle (now Pfizer) and holds a Bachelors of Science degree in Chemistry from Purdue University and an M.B.A degree from Temple University, both with honors.

For more information, go to www.paragonrx.com.

SOURCE ParagonRx


'/>"/>
SOURCE ParagonRx
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
2. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
3. Xytis Names Gordon H. Busenbark as Chief Financial Officer
4. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
5. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
6. California Cryobank Names Richard Jennings President of FamilyCord Division
7. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
8. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
9. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
10. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
11. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology:
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):